Sex differences in the relationship between quit attempt and smoking cessation self-efficacy in adults with depressive symptoms

IF 3.7 2区医学 Q1 PSYCHOLOGY, CLINICAL

Addictive behaviors Pub Date : 2025-03-13 DOI:10.1016/j.addbeh.2025.108328

Zainab S. Shah , Sarah E. Dreyer-Oren , Sarah Barter , Julie A. Desaulniers , Lisa A. Uebelacker , Ana M. Abrantes

{"title":"Sex differences in the relationship between quit attempt and smoking cessation self-efficacy in adults with depressive symptoms","authors":"Zainab S. Shah , Sarah E. Dreyer-Oren , Sarah Barter , Julie A. Desaulniers , Lisa A. Uebelacker , Ana M. Abrantes","doi":"10.1016/j.addbeh.2025.108328","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>Smoking self-efficacy is a key predictor of being able to maintain smoking cessation. Smokers with depression have lower confidence that they can abstain from smoking (i.e., lower smoking self-efficacy) than those without depression. Additionally, individuals assigned female at birth (AFAB) have greater difficulty quitting smoking and lower self-efficacy than those assigned male at birth (AMAB). However, limited attention has been given to the experience of making a quit attempt on changes in smoking self-efficacy among smokers with depressive symptoms and how this may differ by abstinence outcomes and sex. The purpose of the current study was to examine whether abstinence or a reduction in cigarettes smoked during a standard smoking cessation treatment predicted post-treatment changes in smoking self-efficacy, and whether assigned sex moderated this relationship.</div></div><div><h3>Methods</h3><div>Participants (n = 146; 72.6 % AFAB; mean age = 46.6 years) received 12-week standard smoking cessation treatment as part of a randomized controlled trial testing two adjunctive health- and fitness-based interventions. Pre- and post-treatment, participants reported smoking self-efficacy (i.e., confidence abstaining in negative/affective-, positive/social-, and habit/addiction-related situations).</div></div><div><h3>Results</h3><div>Multiple regression analyses showed that abstinence was associated with higher increases in smoking self-efficacy in all facets, and decreasing cigarette use from baseline to post-treatment was significantly associated with increases in total smoking self-efficacy. AMAB smokers had higher levels of positive/social related smoking self-efficacy than did AFAB smokers, and for AFAB smokers, a reduction in cigarettes smoked was associated with greater positive/social smoking self-efficacy.</div></div><div><h3>Conclusions</h3><div>Findings related to the role of self-efficacy in smoking cessation outcomes of smokers with depressive symptoms and how assigned sex impacts the role of self-efficacy provide insight for smoking cessation outcomes. Future research is needed to understand mechanisms underlying smoking self-efficacy and to improve smoking cessation interventions.</div></div>","PeriodicalId":7155,"journal":{"name":"Addictive behaviors","volume":"166 ","pages":"Article 108328"},"PeriodicalIF":3.7000,"publicationDate":"2025-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Addictive behaviors","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0306460325000875","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHOLOGY, CLINICAL","Score":null,"Total":0}

引用次数: 0

Abstract

Objective

Smoking self-efficacy is a key predictor of being able to maintain smoking cessation. Smokers with depression have lower confidence that they can abstain from smoking (i.e., lower smoking self-efficacy) than those without depression. Additionally, individuals assigned female at birth (AFAB) have greater difficulty quitting smoking and lower self-efficacy than those assigned male at birth (AMAB). However, limited attention has been given to the experience of making a quit attempt on changes in smoking self-efficacy among smokers with depressive symptoms and how this may differ by abstinence outcomes and sex. The purpose of the current study was to examine whether abstinence or a reduction in cigarettes smoked during a standard smoking cessation treatment predicted post-treatment changes in smoking self-efficacy, and whether assigned sex moderated this relationship.

Methods

Participants (n = 146; 72.6 % AFAB; mean age = 46.6 years) received 12-week standard smoking cessation treatment as part of a randomized controlled trial testing two adjunctive health- and fitness-based interventions. Pre- and post-treatment, participants reported smoking self-efficacy (i.e., confidence abstaining in negative/affective-, positive/social-, and habit/addiction-related situations).

Results

Multiple regression analyses showed that abstinence was associated with higher increases in smoking self-efficacy in all facets, and decreasing cigarette use from baseline to post-treatment was significantly associated with increases in total smoking self-efficacy. AMAB smokers had higher levels of positive/social related smoking self-efficacy than did AFAB smokers, and for AFAB smokers, a reduction in cigarettes smoked was associated with greater positive/social smoking self-efficacy.

Conclusions

Findings related to the role of self-efficacy in smoking cessation outcomes of smokers with depressive symptoms and how assigned sex impacts the role of self-efficacy provide insight for smoking cessation outcomes. Future research is needed to understand mechanisms underlying smoking self-efficacy and to improve smoking cessation interventions.

查看原文本刊更多论文

成人抑郁症患者戒烟尝试与戒烟自我效能关系的性别差异

目的吸烟自我效能感是能否维持戒烟的关键预测指标。与没有抑郁症的吸烟者相比，患有抑郁症的吸烟者对自己戒烟的信心较低（即吸烟自我效能较低）。此外，出生时被指定为女性（AFAB）的个体比出生时被指定为男性（AMAB）的个体戒烟困难更大，自我效能感更低。然而，很少有人关注有抑郁症状的吸烟者在戒烟过程中自我效能的变化，以及这种变化如何因戒烟结果和性别而有所不同。当前研究的目的是检验在标准戒烟治疗期间戒烟或减少吸烟是否能预测治疗后吸烟自我效能的变化，以及性别分配是否会调节这种关系。方法研究对象(n = 146；72.6% afab；平均年龄= 46.6岁)接受了12周的标准戒烟治疗，作为随机对照试验的一部分，测试了两种辅助健康和健身干预措施。在治疗前和治疗后，参与者报告了吸烟自我效能（即，在消极/情感，积极/社会和习惯/成瘾相关的情况下的信心戒除）。结果多元回归分析显示，戒烟与吸烟自我效能感的各方面均有较高的相关性，从治疗前到治疗后减少吸烟量与总体吸烟自我效能感的升高显著相关。与AFAB吸烟者相比，AMAB吸烟者具有更高水平的积极/社会相关吸烟自我效能感，并且对于AFAB吸烟者来说，吸烟减少与更高的积极/社会吸烟自我效能感相关。结论自我效能感在伴有抑郁症状的吸烟者戒烟结果中的作用，以及性别分配如何影响自我效能感的作用，这些发现为戒烟结果提供了新的见解。未来的研究需要了解吸烟自我效能的潜在机制，并改善戒烟干预措施。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Addictive behaviors 医学-药物滥用

CiteScore

8.40

自引率

4.50%

发文量

283

审稿时长

46 days

期刊介绍： Addictive Behaviors is an international peer-reviewed journal publishing high quality human research on addictive behaviors and disorders since 1975. The journal accepts submissions of full-length papers and short communications on substance-related addictions such as the abuse of alcohol, drugs and nicotine, and behavioral addictions involving gambling and technology. We primarily publish behavioral and psychosocial research but our articles span the fields of psychology, sociology, psychiatry, epidemiology, social policy, medicine, pharmacology and neuroscience. While theoretical orientations are diverse, the emphasis of the journal is primarily empirical. That is, sound experimental design combined with valid, reliable assessment and evaluation procedures are a requisite for acceptance. However, innovative and empirically oriented case studies that might encourage new lines of inquiry are accepted as well. Studies that clearly contribute to current knowledge of etiology, prevention, social policy or treatment are given priority. Scholarly commentaries on topical issues, systematic reviews, and mini reviews are encouraged. We especially welcome multimedia papers that incorporate video or audio components to better display methodology or findings. Studies can also be submitted to Addictive Behaviors? companion title, the open access journal Addictive Behaviors Reports, which has a particular interest in ''non-traditional'', innovative and empirically-oriented research such as negative/null data papers, replication studies, case reports on novel treatments, and cross-cultural research.